276 related articles for article (PubMed ID: 22981681)
1. Gene therapy for primary immunodeficiencies: Part 1.
Cavazzana-Calvo M; Fischer A; Hacein-Bey-Abina S; Aiuti A
Curr Opin Immunol; 2012 Oct; 24(5):580-4. PubMed ID: 22981681
[TBL] [Abstract][Full Text] [Related]
2. Gene therapy for PIDs: progress, pitfalls and prospects.
Mukherjee S; Thrasher AJ
Gene; 2013 Aug; 525(2):174-81. PubMed ID: 23566838
[TBL] [Abstract][Full Text] [Related]
3. Evolving Gene Therapy in Primary Immunodeficiency.
Thrasher AJ; Williams DA
Mol Ther; 2017 May; 25(5):1132-1141. PubMed ID: 28366768
[TBL] [Abstract][Full Text] [Related]
4. Gene therapy for primary immunodeficiencies.
Thrasher AJ
Immunol Allergy Clin North Am; 2008 May; 28(2):457-71, xi. PubMed ID: 18424342
[TBL] [Abstract][Full Text] [Related]
5. Gene therapy for inherited immunodeficiency.
Touzot F; Hacein-Bey-Abina S; Fischer A; Cavazzana M
Expert Opin Biol Ther; 2014 Jun; 14(6):789-98. PubMed ID: 24823313
[TBL] [Abstract][Full Text] [Related]
6. Gene transfer into hematopoietic stem cells as treatment for primary immunodeficiency diseases.
Candotti F
Int J Hematol; 2014 Apr; 99(4):383-92. PubMed ID: 24488786
[TBL] [Abstract][Full Text] [Related]
7. Gene therapy for primary adaptive immune deficiencies.
Fischer A; Hacein-Bey-Abina S; Cavazzana-Calvo M
J Allergy Clin Immunol; 2011 Jun; 127(6):1356-9. PubMed ID: 21624615
[TBL] [Abstract][Full Text] [Related]
8. Gene therapy of inherited immunodeficiencies.
Santilli G; Thornhill SI; Kinnon C; Thrasher AJ
Expert Opin Biol Ther; 2008 Apr; 8(4):397-407. PubMed ID: 18352845
[TBL] [Abstract][Full Text] [Related]
9. Ten years of gene therapy for primary immune deficiencies.
Aiuti A; Roncarolo MG
Hematology Am Soc Hematol Educ Program; 2009; ():682-9. PubMed ID: 20008254
[TBL] [Abstract][Full Text] [Related]
10. Update on gene therapy for immunodeficiencies.
Kohn DB
Clin Immunol; 2010 May; 135(2):247-54. PubMed ID: 20071242
[TBL] [Abstract][Full Text] [Related]
11. Update on gene therapy for adenosine deaminase-deficient severe combined immunodeficiency.
Ferrua F; Brigida I; Aiuti A
Curr Opin Allergy Clin Immunol; 2010 Dec; 10(6):551-6. PubMed ID: 20966749
[TBL] [Abstract][Full Text] [Related]
12. Gene therapy for primary immunodeficiencies: current status and future prospects.
Qasim W; Gennery AR
Drugs; 2014 Jun; 74(9):963-9. PubMed ID: 24848753
[TBL] [Abstract][Full Text] [Related]
13. Gene Therapy for X-Linked Severe Combined Immunodeficiency: Where Do We Stand?
Cavazzana M; Six E; Lagresle-Peyrou C; André-Schmutz I; Hacein-Bey-Abina S
Hum Gene Ther; 2016 Feb; 27(2):108-16. PubMed ID: 26790362
[TBL] [Abstract][Full Text] [Related]
14. Gene therapy for primary immunodeficiencies: Part 2.
Aiuti A; Bacchetta R; Seger R; Villa A; Cavazzana-Calvo M
Curr Opin Immunol; 2012 Oct; 24(5):585-91. PubMed ID: 22909900
[TBL] [Abstract][Full Text] [Related]
15. A tale of two SCIDs.
Shaw KL; Kohn DB
Sci Transl Med; 2011 Aug; 3(97):97ps36. PubMed ID: 21865536
[TBL] [Abstract][Full Text] [Related]
16. Perspectives of gene therapy for primary immunodeficiencies.
Chinen J; Puck JM
Curr Opin Allergy Clin Immunol; 2004 Dec; 4(6):523-7. PubMed ID: 15640693
[TBL] [Abstract][Full Text] [Related]
17. Gene therapy of primary T cell immunodeficiencies.
Fischer A; Hacein-Bey-Abina S; Cavazzana-Calvo M
Gene; 2013 Aug; 525(2):170-3. PubMed ID: 23583799
[TBL] [Abstract][Full Text] [Related]
18. Gene therapy for severe combined immunodeficiencies and beyond.
Fischer A; Hacein-Bey-Abina S
J Exp Med; 2020 Jan; 217(2):. PubMed ID: 31826240
[TBL] [Abstract][Full Text] [Related]
19. Lentiviral vectors for the treatment of primary immunodeficiencies.
Farinelli G; Capo V; Scaramuzza S; Aiuti A
J Inherit Metab Dis; 2014 Jul; 37(4):525-33. PubMed ID: 24619149
[TBL] [Abstract][Full Text] [Related]
20. Modern management of primary T-cell immunodeficiencies.
Pachlopnik Schmid J; Güngör T; Seger R
Pediatr Allergy Immunol; 2014 Jun; 25(4):300-13. PubMed ID: 24383740
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]